|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
58,160,000 |
Market
Cap: |
5.82(B) |
Last
Volume: |
5,449,206 |
Avg
Vol: |
5,398,192 |
52
Week Range: |
$99.99 - $99.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Behan Dominic P |
EVP & Chief Scientific Officer |
|
2013-09-10 |
4 |
AS |
$6.31 |
$1,261,020 |
D/D |
(200,000) |
453,000 |
|
- |
|
Behan Dominic P |
EVP & Chief Scientific Officer |
|
2013-09-10 |
4 |
OE |
$1.49 |
$314,000 |
D/D |
200,000 |
653,000 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2013-09-05 |
4 |
AS |
$6.54 |
$130,726 |
D/D |
(20,000) |
71,046 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2013-09-05 |
4 |
OE |
$1.49 |
$29,800 |
D/D |
20,000 |
91,046 |
|
- |
|
Lief Jack |
Chairman, President and CEO |
|
2013-08-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
542,882 |
|
- |
|
Woods Randall E |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
19,728 |
|
- |
|
White Christine Anna |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
38,728 |
|
- |
|
Hixson Harry F Jr |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
98,112 |
|
- |
|
Bice Scott H |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
23,628 |
|
- |
|
Nova Tina Susan |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
18,728 |
|
- |
|
Schneider Phillip M |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
28,728 |
|
- |
|
Belcher Donald D |
Director |
|
2013-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,728 |
68,728 |
|
- |
|
Audet Craig Michael |
SVP, Opn & Head Glob Reg Afrs |
|
2013-05-21 |
4 |
S |
$8.00 |
$670,000 |
D/D |
(83,750) |
15,000 |
|
- |
|
Audet Craig Michael |
SVP, Opn & Head Glob Reg Afrs |
|
2013-05-21 |
4 |
OE |
$1.28 |
$131,713 |
D/D |
83,750 |
98,750 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2013-04-01 |
4 |
AS |
$8.21 |
$585,126 |
D/D |
(71,250) |
19,570 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2013-04-01 |
4 |
OE |
$1.81 |
$128,963 |
D/D |
71,250 |
90,820 |
|
- |
|
Audet Craig Michael |
SVP, Opn & Head Glob Reg Afrs |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
Behan Dominic P |
EVP & Chief Scientific Officer |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
453,000 |
|
- |
|
Spector Steven W |
EVP, General Counsel & Sec |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
69,943 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,382 |
|
- |
|
Shanahan William R Jr |
SVP & Chief Medical Officer |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
Lief Jack |
Chairman, President and CEO |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
546,007 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2012-10-01 |
4 |
AS |
$8.32 |
$415,980 |
D/D |
(50,000) |
3,382 |
|
- |
|
Hoffman Robert |
SVP, Finance and CFO |
|
2012-10-01 |
4 |
OE |
$1.48 |
$74,000 |
D/D |
50,000 |
53,382 |
|
- |
|
Hixson Harry F Jr |
Director |
|
2012-08-08 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,309 |
0 |
|
- |
|
415 Records found
|
|
Page 11 of 17 |
|
|